Table 1

Ratings* of the six selected occupational health guidelines for low back pain on AGREE items

Canada4 (Quebec)Australia5 (Victoria)USA6New Zealand7–9Netherlands10UK11–14
*Rating “1” means quality item was met; rating “0” means quality item was not met or unclear.
1. The overall objective(s) of the guideline is (are) specifically described.111011
2. The clinical question(s) covered by the guideline is (are) specifically described.001111
3. The patients to whom the guideline is meant to apply are specifically described.011010
4. The guideline development group includes individuals from all the relevant professional groups.110101
5. The patients’ views and preferences have been sought.010100
6. The target users of the guideline are clearly defined.011111
7. The guideline has been piloted among target users.001010
8. Systematic methods were used to search for evidence.100001
9. The criteria for selecting the evidence are clearly described.100001
10. The methods used for formulating the recommendations are clearly described.000001
11. The health benefits, side effects and risks have been considered in formulating the recommendations.001011
12. There is an explicit link between the recommendations and the supporting evidence.101001
13. The guideline has been externally reviewed by experts prior to its publication.000000
14. A procedure for updating the guideline is provided.000001
15. The recommendations are specific and unambiguous.001011
16. The different options for management of the condition are clearly presented.111111
17. Key recommendations are easily identifiable.101111
18. The guideline is supported with tools for application.000111
19. The potential organisational barriers in applying the recommendations have been discussed.000000
20. The potential cost implications of applying the recommendations have been considered.000000
21. The guideline presents key review criteria for monitoring and/or audit purposes.111101
22. The guideline is editorially independent from the funding body.000000
23. Conflicts of interest of guideline development members have been recorded.000000